Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

13:12 IST BSE
Board Meeting DateMangal Electrical Industries Ltd MEIL

Mangal Electrical Industries Board Meeting Date

Mangal Electrical Industries Ltd has scheduled a Board Meeting on May 13, 2026, to approve audited financial results for the year ended March 31, 2026. The board will also consider granting Employee Stock Options. Consequently, the trading window for designated persons remains closed until 48 hours after the results declaration.

13:07 IST BSE
Promoter Buying (Off-Market)Thakral Services (India) Ltd THAKRAL

Thakral Services (India) Promoter Buying (Off-Market): ₹13.03 Cr

Netizen Properties Private Limited is set to acquire a 74% stake (86,84,200 shares) in Thakral Services (India) Limited from promoter Paramount Park Limited. The off-market transaction, valued at approximately ₹13.24 Crore (₹15.25 per share), represents an internal restructuring within the promoter group with no change in ultimate beneficial ownership.

Value
₹13.03 Cr
13:04 IST BSE
Product LaunchAvi Polymers Ltd 539288

Avi Polymers Product Launch

AVI Polymers Ltd launched its 'Ashwini Healthcare AI' platform, securing over 5,620 registered users. The company anticipates an initial cohort of 600-900 paying subscribers, projecting a Year-1 baseline ARR of ₹0.06 Crore to ₹0.09 Crore. Long-term targets include scaling to ₹12 Crore ARR for Series-A valuation metrics.

Value
₹0.06 Cr
Execution
Year-1
12:49 IST NSE
Regulatory ApprovalPrivi Speciality Chemicals Ltd PRIVISCL

Privi Speciality Chemicals Regulatory Approval

Privi Speciality Chemicals Limited received a 'no objection' observation letter from NSE for its merger scheme with Privi Fine Sciences and Privi Biotechnologies. Approval from BSE is currently awaited. The amalgamation remains subject to further regulatory and statutory clearances.